References
- Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390:1211–1259.
- Sheps DS, McMahon RP, Becker L, et al. Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: results from the psychophysiological investigations of myocardial ischemia study. Circulation. 2002;105:1780–1784.
- Feigal JP, Boyle SH, Samad Z, et al. Associations between positive emotional well-being and stress-induced myocardial ischemia: well-being scores predict exercise-induced ischemia. J Psychosom Res. 2017;93:14–18.
- Zhang LJ, He DF, Yang Y, et al. A clinical study of mental stress-induced myocardial ischemia in patients with stable coronary artery disease and depression/anxiety. Zhonghua Nei Ke Za Zhi. 2018;57:494–499.
- Kaufmann PG, McMahon RP, Becker LC, et al. The Psychophysiological Investigations of Myocardial Ischemia (PIMI) study: objective, methods, and variability of measures. Psychosom Med. 1998;60:56–63.
- Lu XT, Zhao YX, Zhang Y, et al. Psychological stress, vascular inflammation, and atherogenesis: potential roles of circulating cytokines. J Cardiovasc Pharmacol. 2013;62:6–12.
- Kop WJ, Weissman NJ, Zhu J, et al. Effects of acute mental stress and exercise on inflammatory markers in patients with coronary artery disease and healthy controls. Am J Cardiol. 2008;101:767–773.
- Ackerman KD, Martino M, Heyman R, et al. Stressor-induced alteration of cytokine production in multiple sclerosis patients and controls. Psychosom Med. 1998;60:484–491.
- Marsland AL, Walsh C, Lockwood K, et al. The effects of acute psychological stress on circulating and stimulated inflammatory markers: A systematic review and meta-analysis. Brain Behav Immun. 2017;64:208–219.
- Hammadah M, Sullivan S, Pearce B, et al. Inflammatory response to mental stress and mental stress induced myocardial ischemia. Brain Behav Immun. 2018;68:90–97.
- Tajfard M, Tavakoly Sany SB, Avan A, et al. Relationship between serum high sensitivity C-reactive protein with angiographic severity of coronary artery disease and traditional cardiovascular risk factors. J Cell Physiol. 2019;234:10289–10299.
- Kosar F, Aksoy Y, Ozguntekin G, et al. Relationship between cytokines and tumour markers in patients with chronic heart failure. Eur J Heart Fail. 2006;8:270–274.
- Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236–241.
- Tunon J, Blanco-Colio L, Cristobal C, et al. Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease. Am J Cardiol. 2014;113:434–440.
- Tajfard M, Latiff LA, Rahimi HR, et al. Serum concentrations of MCP-1 and IL-6 in combination predict the presence of coronary artery disease and mortality in subjects undergoing coronary angiography. Mol Cell Biochem. 2017;435:37–45.
- Roy MS, Janal MN, Crosby J, et al. Plasma markers of inflammation and prediction of cardiovascular disease and mortality in African Americans with type 1 diabetes. Diabetes Res Clin Pract. 2016;114:117–125.
- Mitrokhin V, Nikitin A, Brovkina O, et al. Association between IL-18/18R gene polymorphisms and coronary artery disease: influence of IL-18/18R genetic variants on cytokine expression. J Inflamm Res. 2018;11:1–9.
- Falcone C, Minoretti P, D’Angelo A, et al. Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease. Eur J Clin Invest. 2006;36:211–217.
- Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology. Eur Heart J. 2013;34:2949–3003.
- Specchia G, de Servi S, Falcone C, et al. Mental arithmetic stress testing in patients with coronary artery disease. Am Heart J. 1984;108:56–63.
- Liu MY, Yang Y, Zhang LJ, et al. Potential predictors for mental stress-induced myocardial ischemia in patients with coronary artery disease. Chin Med J (Engl). 2019;132:1390–1399.
- Kuroda T, Kuwabara Y, Watanabe S, et al. Effect of mental stress on left ventricular ejection fraction and its relationship to the severity of coronary artery disease. Eur J Nucl Med. 2000;27:1760–1767.
- Tolentino JC, Schmidt JJ, Schmidt GJ, et al. Mental stress-induced myocardial ischemia related to generalized anxiety disorder in a patient with acute coronary syndrome and normal coronary arteries. Clin Nucl Med. 2016;41:e487–e490.
- Roth DSA, Laniado S. Mental stress and acute myocardial infarction. Am J Emerg Med. 1993;11:431.
- Burg MM, Soufer R. Psychological stress and induced ischemic syndromes. Curr Cardiovasc Risk Rep. 2014;8:377.
- Licinio J, Perry SW, Wong M-L. The depressed heart. Heart Mind. 2019;3:35.
- Grebe KM, Takeda K, Hickman HD, et al. Cutting edge: sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis. J Immunol. 2010;184:540–544.
- Cole SW, Arevalo JM, Takahashi R, et al. Computational identification of gene-social environment interaction at the human IL6 locus. Proc Natl Acad Sci U S A. 2010;107:5681–5686.
- Bhattacharyya MR, Molloy GJ, Steptoe A. Depression is associated with flatter cortisol rhythms in patients with coronary artery disease. J Psychosom Res. 2008;65:107–113.
- Duewell P, Kono H, Rayner KJ, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010;464:1357–1361.
- Ridker PM, MacFadyen JG, Glynn RJ, et al. Inhibition of interleukin-1beta by canakinumab and cardiovascular outcomes in patients with chronic kidney disease. J Am Coll Cardiol. 2018;71:2405–2414.
- Amdur RL, Feldman HI, Dominic EA, et al. Use of measures of inflammation and kidney function for prediction of atherosclerotic vascular disease events and death in Patients with CKD: findings from the CRIC study. Am J Kidney Dis. 2019;73:344–353.
- Zhu Y, Klomparens EA, Guo S, et al. Neuroinflammation caused by mental stress: the effect of chronic restraint stress and acute repeated social defeat stress in mice. Neurol Res. 2019;41:762–769.
- Ellins E, Halcox J, Donald A, et al. Arterial stiffness and inflammatory response to psychophysiological stress. Brain Behav Immun. 2008;22:941–948.
- Hackett RA, Hamer M, Endrighi R, et al. Loneliness and stress-related inflammatory and neuroendocrine responses in older men and women. Psychoneuroendocrinology. 2012;37:1801–1809.
- Tarzami ST, Calderon TM, Deguzman A, et al. MCP-1/CCL2 protects cardiac myocytes from hypoxia-induced apoptosis by a G(alphai)-independent pathway. Biochem Biophys Res Commun. 2005;335:1008–1016.
- Xia Y, Frangogiannis NG. MCP-1_CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy. Inflamm Allergy Drug Targets. 2007;6:101–107.
- Strazza M, Azoulay-Alfaguter I, Peled M, et al. PLCepsilon1 regulates SDF-1alpha-induced lymphocyte adhesion and migration to sites of inflammation. Proc Natl Acad Sci U S A. 2017;114:2693–2698.
- Kim BS, Jacobs D, Emontzpohl C, et al. Myocardial Ischemia Induces SDF-1alpha release in cardiac surgery patients. J Cardiovasc Transl Res. 2016;9:230–238.